About qsymia.us.com — Independent Drug Information

Who we are

qsymia.us.com is an independent editorial website covering Qsymia (phentermine/topiramate extended-release) and related anti-obesity medications. We are not affiliated with Currax Pharmaceuticals, Vivus, any telehealth platform, or any medication manufacturer. We are not a clinical practice and we do not provide medical advice.

What we publish

Our content is organized around the questions patients actually ask when researching Qsymia: what is it, how does it work, what are the side effects, what does it cost, how do I get it, and how does it compare with the newer GLP-1 class. Each page is written to be understandable without a medical background while citing the underlying primary sources (FDA labeling, peer-reviewed clinical trials) for readers who want to verify or go deeper.

Editorial standards

Primary sources first. Drug data comes from the current FDA-approved prescribing information, the published pivotal trials, and peer-reviewed follow-up literature. Where specific numbers appear, they are traceable to a cited source.
Editorially reviewed. All medical content is reviewed for accuracy against the cited primary sources. We do not use fabricated "reviewed by Dr. X" bylines or invented credentials.
No medical advice. Our job is to explain what the evidence says, not to prescribe. Any decision about starting, stopping, or changing medication belongs to you and your clinician.
Transparent comparisons. When we compare Qsymia with alternative medications, we cite each drug's pivotal trial and note when data is cross-trial (not head-to-head).
Updated as the evidence changes. Pages carry a "last reviewed" date. Significant updates — new label changes, generic launches, new trial data — trigger page revisions.

How we handle affiliate relationships

This site contains affiliate links to US-licensed telehealth platforms that can prescribe FDA-approved GLP-1 medications after a clinician review. If a reader enrolls through one of our links, we may earn a referral fee at no additional cost to the reader.

Affiliate revenue funds our editorial work. It does not change the content of our Qsymia coverage — we say what we think about the drug regardless of whether any particular page has a CTA on it. We disclose the affiliate relationship at the top of every page (the thin bar above the logo) and in the footer.

What we don't do

We do not sell medications directly. Anything you buy from a link on this site is from a third-party US-licensed telehealth platform.
We do not publish patient testimonials, paid reviews, or fabricated case studies.
We do not use AI-generated stock photos of "doctors" to imply medical authority.
We do not accept sponsored content from drug manufacturers.

Contact

Editorial corrections, factual disputes, or other feedback: please reach us through the contact form linked in the footer. We read every message, though we can't respond to individual medical questions — those belong with your clinician.